Product Information
CLARITHROMYCIN ER 500 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $1.9182 per EA under NDC 00591280560. Its NADAC has been published 639 times since Apr 9, 2014.
FDA first approved this application on Jun 24, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the clarithromycin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591280560
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLARITHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA065145FDA Approved
6/24/2004
TE Code
AB
On Market Since
2/27/2014
Pharmacological Classes
Price Statistics
The NADAC for CLARITHROMYCIN ER 500 MG TAB has been published 639 times since Apr 9, 2014, and over the history we have for it it has declined 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9182 per EA |
|---|---|
| All-time high | $6.1881 (Oct 13, 2021) |
| All-time low | $1.8978 (Aug 19, 2026) |
| 52-week high | $3.6782 |
| 52-week low | $1.8978 |
| Median price | $3.3542 |
| Average price | $3.5756 |
| Largest weekly change | +41.5% (Dec 19, 2018) |
| Weeks tracked | 639 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clarithromycin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clarithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARITHROMYCIN ER 500 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN ER 500 MG TAB, manufactured by Actavis Pharma, Inc., is $1.9182 per EA (NDC 00591280560), effective Sep 30, 2026.
How has the price of CLARITHROMYCIN ER 500 MG TAB changed over time?
Over the history we have for it, the NADAC for CLARITHROMYCIN ER 500 MG TAB has declined 21.3%. It has been tracked across 639 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN ER 500 MG TAB?
Since Apr 9, 2014, the NADAC for CLARITHROMYCIN ER 500 MG TAB has ranged from a low of $1.8978 (Aug 19, 2026) to a high of $6.1881 (Oct 13, 2021), with a median of $3.3542 per EA.
Are there cheaper alternatives to CLARITHROMYCIN ER 500 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of CLARITHROMYCIN ER 500 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLARITHROMYCIN ER 500 MG TAB?
CLARITHROMYCIN ER 500 MG TAB (NDC 00591280560) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.